[go: up one dir, main page]

CY1109344T1 - Εμβολιο αδρανοποιημενου nodavirus - Google Patents

Εμβολιο αδρανοποιημενου nodavirus

Info

Publication number
CY1109344T1
CY1109344T1 CY20091100898T CY091100898T CY1109344T1 CY 1109344 T1 CY1109344 T1 CY 1109344T1 CY 20091100898 T CY20091100898 T CY 20091100898T CY 091100898 T CY091100898 T CY 091100898T CY 1109344 T1 CY1109344 T1 CY 1109344T1
Authority
CY
Cyprus
Prior art keywords
nodavirus
vaccine
vaccinated vaccine
fish
vaccinated
Prior art date
Application number
CY20091100898T
Other languages
English (en)
Inventor
Santos Nuno Dos
Jacqueline Ireland
Andrew Cartner Barnes
Michael Horne
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32910468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1109344(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0303867A external-priority patent/GB0303867D0/en
Priority claimed from GB0320195A external-priority patent/GB0320195D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1109344T1 publication Critical patent/CY1109344T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30061—Methods of inactivation or attenuation
    • C12N2770/30063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ένα εμβόλιο κατά της μόλυνσης από τον nodavirus στα ψάρια μπορεί να παραχθεί αδρανοποιώντας τον ιό χρησιμοποιώντας μία ένωση αζιριδίνης. Το εμβόλιο αυτό μπορεί αν χρησιμοποιηθεί για την αποτροπή της Ιογενούς Νευρικής Νέκρωσης (VNN) σε μια πληθώρα ειδών ψαριών.
CY20091100898T 2003-02-19 2009-08-28 Εμβολιο αδρανοποιημενου nodavirus CY1109344T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0303867A GB0303867D0 (en) 2003-02-19 2003-02-19 Organic compounds
GB0320195A GB0320195D0 (en) 2003-08-28 2003-08-28 Organic compounds
EP04712006A EP1597359B1 (en) 2003-02-19 2004-02-18 Inactivated nodavirus vaccine

Publications (1)

Publication Number Publication Date
CY1109344T1 true CY1109344T1 (el) 2014-07-02

Family

ID=32910468

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100898T CY1109344T1 (el) 2003-02-19 2009-08-28 Εμβολιο αδρανοποιημενου nodavirus

Country Status (17)

Country Link
US (2) US20060257425A1 (el)
EP (1) EP1597359B1 (el)
JP (1) JP4664901B2 (el)
AT (1) ATE437224T1 (el)
AU (1) AU2004213566B2 (el)
CA (1) CA2512930C (el)
CL (1) CL2004000282A1 (el)
CY (1) CY1109344T1 (el)
DE (1) DE602004022139D1 (el)
DK (1) DK1597359T3 (el)
ES (1) ES2328141T3 (el)
MY (1) MY143785A (el)
NO (1) NO336878B1 (el)
PT (1) PT1597359E (el)
SI (1) SI1597359T1 (el)
TW (1) TWI347364B (el)
WO (1) WO2004074467A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003262A1 (es) * 2007-11-02 2009-06-26 Intervet Int Bv Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.
KR101608121B1 (ko) * 2012-09-20 2016-04-01 중앙대학교 산학협력단 노다바이러스의 바이러스 유사입자의 생산방법, 이를 발현하는 효모 세포주 및 이를 포함하는 백신 조성물
KR101414009B1 (ko) * 2012-11-16 2014-07-02 주식회사 젠닥스 형질전환 식물체를 이용한 어류 바이러스성 신경괴사증 예방 경구백신 제조방법과 그에 따른 식물체
JP6186079B2 (ja) * 2013-05-28 2017-08-23 ノバルティス ティーアゲズントハイト アーゲー 感染におけるベータノダウイルスの相互作用
JP2019511208A (ja) * 2016-02-02 2019-04-25 ベンチマーク アニマル ヘルス リミテッド ウイルスを作製する方法
CN113429338B (zh) * 2021-05-20 2023-05-02 陕西泰合利华工业有限公司 一种合成氟吡菌酰胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891705A (en) * 1997-04-08 1999-04-06 Pentose Pharmaceuticals, Inc. Method for inactivating a virus
US6274147B1 (en) * 1998-03-31 2001-08-14 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts
TWI220904B (en) * 1998-12-03 2004-09-11 Nat Science Council An immortal cell line derived from grouper Epinephelus coioides and its applications therein
US20040001863A1 (en) * 1998-12-03 2004-01-01 Shau-Chi Chi Immortal cell line derived from grouper Epinephelus coioides and its applications therein
JP2001161355A (ja) * 1999-11-25 2001-06-19 Natl Sci Council ハタ科チャイロマルハタから得られる不死の細胞株およびその応用
AU2002233969A1 (en) * 2001-12-07 2003-06-23 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US20050118194A1 (en) * 2003-12-01 2005-06-02 Sin Yoke M. Oral vaccine, method for its preparation and use thereof

Also Published As

Publication number Publication date
DE602004022139D1 (el) 2009-09-03
AU2004213566B2 (en) 2007-08-23
CL2004000282A1 (es) 2005-03-28
PT1597359E (pt) 2009-08-06
JP4664901B2 (ja) 2011-04-06
ATE437224T1 (de) 2009-08-15
NO20054219D0 (no) 2005-09-12
ES2328141T3 (es) 2009-11-10
SI1597359T1 (sl) 2009-12-31
EP1597359A1 (en) 2005-11-23
NO20054219L (no) 2005-09-12
AU2004213566A1 (en) 2004-09-02
US20060257425A1 (en) 2006-11-16
US8124100B2 (en) 2012-02-28
WO2004074467A1 (en) 2004-09-02
US20090288179A1 (en) 2009-11-19
HK1085765A1 (en) 2006-09-01
NO336878B1 (no) 2015-11-23
MY143785A (en) 2011-07-15
TWI347364B (en) 2011-08-21
DK1597359T3 (da) 2009-11-16
JP2006517943A (ja) 2006-08-03
TW200425899A (en) 2004-12-01
CA2512930C (en) 2015-06-02
EP1597359B1 (en) 2009-07-22
CA2512930A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
CY1109344T1 (el) Εμβολιο αδρανοποιημενου nodavirus
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
EA200500584A1 (ru) Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
NO20070751L (no) Inhibitorer av HCV-replifikasjon
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
UY28525A1 (es) Péptidos macrociclicos activos contra en virus de la hepatitis c
CY1113038T1 (el) Τριετεροκυκλικες ενωσεις, συνθεσεις, και μεθοδοι για τη θεραπεια καρκινου
MA32633B1 (fr) Formes cristallines d'un derive 2-thiazolyl-4-quinolinyl-oxy, un inhibiteur puissant du vhc
EA200800932A1 (ru) Модифицированные 4`-нуклеозиды в качестве противовирусных агентов
DK1569929T3 (da) Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
ATE547103T1 (de) Hemmer des hepatitis-c-virus
EA201000277A1 (ru) Соединения для лечения гепатита с
DK1654261T3 (da) Hepatitis C-inhibitorforbindelser
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
EA200700243A1 (ru) Способы лечения гепатита с
GEP20063938B (en) Hepatitis c virus inhibitors
EA201270275A1 (ru) Кристаллическое соединение пиридазина
CO2022006965A2 (es) Inhibidores de egfr
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
EA201070281A1 (ru) Производные индол-2-она, двузамещенные в положении 3, их получение и их применение в терапии
EA200801251A1 (ru) Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма
DE602006014720D1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
DE602005008264D1 (de) Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion
ATE359815T1 (de) Streptococcus-phocae-vakzine